Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

rac-18-Meth-oxy-coronaridine hydro-chloride.

Kuehne ME, Waterman R.

Acta Crystallogr Sect E Struct Rep Online. 2012 Apr 1;68(Pt 4):o1041. doi: 10.1107/S1600536812009981. Epub 2012 Mar 10.

2.

Anti-HIV-1 activity of the Iboga alkaloid congener 18-methoxycoronaridine.

Silva EM, Cirne-Santos CC, Frugulhetti IC, Galvão-Castro B, Saraiva EM, Kuehne ME, Bou-Habib DC.

Planta Med. 2004 Sep;70(9):808-12.

PMID:
15386189
3.

Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration.

Pace CJ, Glick SD, Maisonneuve IM, He LW, Jokiel PA, Kuehne ME, Fleck MW.

Eur J Pharmacol. 2004 May 25;492(2-3):159-67.

PMID:
15178360
4.

Syntheses and biological evaluation of vinblastine congeners.

Kuehne ME, Bornmann WG, Markó I, Qin Y, LeBoulluec KL, Frasier DA, Xu F, Mulamba T, Ensinger CL, Borman LS, Huot AE, Exon C, Bizzarro FT, Cheung JB, Bane SL.

Org Biomol Chem. 2003 Jun 21;1(12):2120-36. Erratum in: Org Biomol Chem. 2003 Jul 7;1(13):2403.

PMID:
12945903
5.

Synthesis and biological evaluation of 18-methoxycoronaridine congeners. Potential antiaddiction agents.

Kuehne ME, He L, Jokiel PA, Pace CJ, Fleck MW, Maisonneuve IM, Glick SD, Bidlack JM.

J Med Chem. 2003 Jun 19;46(13):2716-30.

PMID:
12801235
6.

Interaction of tubulin with a new fluorescent analogue of vinblastine.

Chatterjee SK, Laffray J, Patel P, Ravindra R, Qin Y, Kuehne ME, Bane SL.

Biochemistry. 2002 Nov 26;41(47):14010-8.

PMID:
12437358
7.
8.

In vitro activities of iboga alkaloid congeners coronaridine and 18-methoxycoronaridine against Leishmania amazonensis.

Delorenzi JC, Freire-de-Lima L, Gattass CR, de Andrade Costa D, He L, Kuehne ME, Saraiva EM.

Antimicrob Agents Chemother. 2002 Jul;46(7):2111-5.

9.

Metabolism of 18-methoxycoronaridine, an ibogaine analog, to 18-hydroxycoronaridine by genetically variable CYP2C19.

Zhang W, Ramamoorthy Y, Tyndale RF, Glick SD, Maisonneuve IM, Kuehne ME, Sellers EM.

Drug Metab Dispos. 2002 Jun;30(6):663-9.

PMID:
12019193
11.

The syntheses of 16a'-homo-leurosidine and 16a'-homo-vinblastine. Generation of atropisomers.

Kuehne ME, Qin Y, Huot AE, Bane SL.

J Org Chem. 2001 Aug 10;66(16):5317-28.

PMID:
11485450
12.
13.
14.

Biogenetic syntheses of kopsijasminilam and deoxykopsijasminilam.

Kuehne ME, Li YL, Wei CQ.

J Org Chem. 2000 Oct 6;65(20):6434-40.

PMID:
11052086
15.

A biomimetic synthesis of the pauciflorine A and B skeleton.

Kuehne ME, Li YL.

Org Lett. 1999 Dec 2;1(11):1749-50. Erratum in: Org Lett 2000 Jan;2(1):97.

PMID:
10836035
16.

A Biomimetic Synthesis of the Pauciflorine A and B Skeleton.

Kuehne ME, Li YL.

Org Lett. 2000 Jan 13;2(1):97. No abstract available.

PMID:
10814255
17.

18-Methoxycoronardine attenuates nicotine-induced dopamine release and nicotine preferences in rats.

Glick SD, Maisonneuve IM, Visker KE, Fritz KA, Bandarage UK, Kuehne ME.

Psychopharmacology (Berl). 1998 Oct;139(3):274-80.

PMID:
9784085
18.

Acute iboga alkaloid effects on extracellular serotonin (5-HT) levels in nucleus accumbens and striatum in rats.

Wei D, Maisonneuve IM, Kuehne ME, Glick SD.

Brain Res. 1998 Aug 3;800(2):260-8.

PMID:
9685673
19.

Time-dependent interactions between iboga agents and cocaine.

Maisonneuve IM, Visker KE, Mann GL, Bandarage UK, Kuehne ME, Glick SD.

Eur J Pharmacol. 1997 Oct 8;336(2-3):123-6.

PMID:
9384223
20.

Attenuation of alcohol consumption by a novel nontoxic ibogaine analogue (18-methoxycoronaridine) in alcohol-preferring rats.

Rezvani AH, Overstreet DH, Yang Y, Maisonneuve IM, Bandarage UK, Kuehne ME, Glick SD.

Pharmacol Biochem Behav. 1997 Oct;58(2):615-9.

PMID:
9300627
22.

Structurally modified ibogaine analogs exhibit differing affinities for NMDA receptors.

Layer RT, Skolnick P, Bertha CM, Bandarage UK, Kuehne ME, Popik P.

Eur J Pharmacol. 1996 Aug 8;309(2):159-65.

PMID:
8874134
23.

18-Methoxycoronaridine, a non-toxic iboga alkaloid congener: effects on morphine and cocaine self-administration and on mesolimbic dopamine release in rats.

Glick SD, Kuehne ME, Maisonneuve IM, Bandarage UK, Molinari HH.

Brain Res. 1996 May 6;719(1-2):29-35.

PMID:
8782860
24.

Ibogaine and its congeners are sigma 2 receptor-selective ligands with moderate affinity.

Bowen WD, Vilner BJ, Williams W, Bertha CM, Kuehne ME, Jacobson AE.

Eur J Pharmacol. 1995 Jun 6;279(1):R1-3.

PMID:
7556375
25.
27.

Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies.

Deecher DC, Teitler M, Soderlund DM, Bornmann WG, Kuehne ME, Glick SD.

Brain Res. 1992 Feb 7;571(2):242-7.

PMID:
1377086
28.

Specific alterations in the biological activities of C-20'-modified vinblastine congeners.

Borman LS, Kuehne ME.

Biochem Pharmacol. 1989 Mar 1;38(5):715-24.

PMID:
2930575
29.

Single site-modified congeners of vinblastine dissociate its various anti-microtubule actions.

Borman LS, Kuehne ME, Matson PA, Marko I, Zebovitz TC.

J Biol Chem. 1988 May 25;263(15):6945-8.

30.

The structures of the spiramycins and magnamycin.

Kuehne ME, Benson BW.

J Am Chem Soc. 1965 Oct 20;87(20):4660-2. No abstract available.

PMID:
5845077
31.

STEROIDAL DIHYDRO-1,3-OXAZINES AS ANTITUMOR AGENTS.

KUEHNE ME, KONOPKA EA, LAMBERT BF.

J Med Pharm Chem. 1962 Mar;5:281-96. No abstract available.

PMID:
14051904
32.

DIHYDRO-1,3-OXAZINES AS ANTITUMOR AGENTS.

KUEHNE ME, KONOPKA EA.

J Med Pharm Chem. 1962 Mar;5:257-80. No abstract available.

PMID:
14051903
33.

Rauwolfia alkaloids XXVII: the conversion of 3-isoreserpine to reserpine.

HUEBNER CF, KUEHNE ME, KORZUN B, SCHLITTLER E.

Experientia. 1956 Jul 15;12(7):249-50. No abstract available.

PMID:
13344432

Supplemental Content

Loading ...
Support Center